MDEV (MDEV) Stock Price & Analysis
MDEV (MDEV) rose 1.55% to USD 19.17 as of June 10, 2026 at 05:32 UTC, according to Nexqual real-time market data.
MDEV last closed at USD 18.88; the session ranged USD 19.17–19.22 on volume of 6,045 shares. Market capitalization is —, with a 52-week range of USD 17.85–21.82 (BTS). Source: Nexqual, June 10, 2026 at 05:32 UTC.
Key Statistics (as of June 10, 2026 at 05:32 UTC)
| Price | USD 19.17 |
|---|---|
| Change | ▲ 1.55% (up) |
| Previous Close | USD 18.88 |
| Open | USD 19.21 |
| Day Range | USD 19.17 – 19.22 |
| 52-Week Range | USD 17.85 – 21.82 |
| Volume | 6,045 shares |
| Market Cap | — |
| Exchange | BTS |
Technical Analysis (MDEV)
Nexqual's technical model rates MDEV "BUY" based on 4 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 05:32 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 50.19 (neutral) |
| vs SMA50 | Above (USD 18.86) |
| MACD | 0.02 (positive) |
Financial Health Score (MDEV)
Nexqual rates MDEV's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:32 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ILDR | First Trust Innovation Leaders | USD 37.66 | ▼ 0.11% |
| XPND | First Trust Expanded Technology | USD 39.46 | ▼ 0.01% |
| FTXH | First Trust Nasdaq Pharmaceutic | USD 35.64 | ▲ 0.55% |
| BMED | iShares Health Innovation Activ | USD 28.66 | ▲ 0.7% |
| XHE | State Street SPDR S&P Health Ca | USD 83.11 | ▲ 2.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:32 UTC. This page is informational and not investment advice.